Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oseltamivir phosphate capsule bioequivalence study under fasting and fed conditions
ChiCTR-IPR-17011522Phase 4Not yet recruiting
- Sponsor
- The First Hospital of Jilin University
- Start
- May 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of oseltamivir in influenza (2 arms), sponsored by The First Hospital of Jilin University. Primary endpoints: AUC0-t, AUC0-∞ and 1 more. Planned start May 2017; status: not yet recruiting.
02
Drugs
oseltamivir
03
Conditions
influenza
Beyond the preview
Go deeper on ChiCTR-IPR-17011522.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-IPR-17011522.